New!Protection against lethal vaccinia virus infection in mice using an siRNA targeting the A5R gene
2016 Subscriptions availableOrder the next volume of Antiviral Therapy today.
17th Comorbidities Workshop:Following a very successful meeting in Barcelona, look out for a full meeting report
Founding Editors: Douglas D Richman & Joep MA Lange
Editor-in-Chief: Douglas D Richman
Antiviral Therapy (an official publication of the International Society of Antiviral Research) is an international, peer-reviewed journal devoted to publishing articles on the clinical development and use of antiviral agents and vaccines, and the treatment of all viral diseases. Antiviral Therapy is one of the leading journals in virology and infectious diseases (2013 ISI impact factor: 3.14).
The journal is comprehensive, and publishes articles concerning all clinical aspects of antiviral therapy. It features editorials, original research papers, specially commissioned review articles, letters and book reviews. The journal is aimed at physicians and specialists interested in clinical and basic research.
♦ Immediate online publication
♦ A leading Editorial Board ensuring high-quality standards
♦ Worldwide readership
♦ Inclusion in major indexing and abstracting services
♦ No page charges
ISSN: 1359-6535 (print); 2040-2058 (online)